Biocon Biologics gets EIR from USFDA for Bengaluru facility
Biocon Biologics gets EIR from USFDA for Bengaluru facility

Biocon Biologics gets EIR from USFDA for Bengaluru facility

Apurva Joshi Article rating: 3.0

Biocon Limited’s subsidiary Biocon Biologics India Ltd has received an establishment inspection report (EIR) from USFDA for the pre-approval inspection (PAI) at two of its biologics manufacturing facilities in Bengaluru.

TCS partners with Israels first fully-digital bank
TCS partners with Israels first fully-digital bank

TCS partners with Israels first fully-digital bank

DSIJ Intelligence Article rating: 4.7

Tata Consultancy Services (TCS) has announced that Israel’s first fully-digital bank has partnered with TCS as the first customer of its banking service bureau, powered by TCS BaNCS.

Index trend and stocks in action on April 16, 2020
Index trend and stocks in action on April 16, 2020

Index trend and stocks in action on April 16, 2020

DSIJ Intelligence-3 Article rating: 5.0

The range of 8,650-9,390 is a crucial range to keep a watch out and break on the either side of the range, which would lead to a directional move. Stocks in news: Shree Cement, Endurance Technologies, Escorts, Galaxy Surfactants, Navin Fluorine International, Prataap Snacks.

Negative start for the markets!
Negative start for the markets!

Negative start for the markets!

DSIJ Intelligence-3 Article rating: 5.0

The onslaught by bear that began in the second half of the trading session is likely to continue today as well, since SGX Nifty indicates a negative start for the markets. Global cues are also dreadful on the back of weak US economic data as corporate earnings has been severely impacted by the spread of COVID-19.

Basics of personal finance
Basics of personal finance

Basics of personal finance

DSIJ Intelligence Article rating: 2.8

It is rightly said that the quality of anything is defined by its foundation. Therefore, in this article, we will discuss all the basic concepts of personal finance.

Zydus receive tentative USFDA approval for Macitentan tablets
Zydus receive tentative USFDA approval for Macitentan tablets

Zydus receive tentative USFDA approval for Macitentan tablets

DSIJ Intelligence Article rating: 3.7

On Wednesday, Zydus Worldwide DMCC, a wholly-owned subsidiary of Cadila Healthcare Limited, announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) to market Macitentan tablets (US RLD: Opsumit tablets), 10 mg.

Moodys to review JSW Steel rating for downgrade
Moodys to review JSW Steel rating for downgrade

Moodys to review JSW Steel rating for downgrade

DSIJ Intelligence Article rating: 4.8

The international rating agency, Moody’s Investor Services said that it has placed JSW Steel Limited’s rating under review for downgrade on the back of the company’s severe exposure to the ongoing Coronavirus outbreak and its subsequent fall in steel demand.

COVID-19 to shrink global economy
COVID-19 to shrink global economy

COVID-19 to shrink global economy

DSIJ Intelligence Article rating: 5.0

The global economy is expected to shrink by 3.0 per cent during 2020 due to Coronavirus-driven collapse of activity. This will mark the steepest downturn since the Great Depression of 1930s as per International Monetary Fund (IMF)

Sensex erases opening gains
Sensex erases opening gains

Sensex erases opening gains

DSIJ Intelligence Article rating: 5.0

On Wednesday, Sensex closed down by 1.01 per cent, which is 310.21 points to be at 30,379.81 levels. Nifty also fell by 0.76 per cent which is 68.55 points to 8,925.30 levels. The morning session had witnessed Sensex rising over 700 points along with Nifty, gaining by more than 200 points as global peers were positive.

RSS
First30773078307930803082308430853086Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR